ODC1 and cancer: Additionally, several other PLP-dependent enzymes have already been exploited as drug targets such as the γ-aminobutyric acid GABA aminotransferase by the drug vigabatrin for treatment of epilepsy [60], the alanine racemase in microbicides [61], or the ornithine decarboxylase (ODC) in cancer research [62].